A detailed history of Ibex Investors LLC transactions in Intercure Ltd. stock. As of the latest transaction made, Ibex Investors LLC holds 1,889,658 shares of INCR stock, worth $2.21 Million. This represents 9.38% of its overall portfolio holdings.

Number of Shares
1,889,658
Previous 1,889,658 -0.0%
Holding current value
$2.21 Million
Previous $3.8 Million -0.0%
% of portfolio
9.38%
Previous 7.67%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$1.01 - $1.62 $16,782 - $26,917
-16,616 Reduced 0.87%
1,889,658 $2.44 Million
Q3 2023

Nov 08, 2023

BUY
$1.39 - $1.72 $4,865 - $6,020
3,500 Added 0.18%
1,906,274 $2.99 Million
Q4 2022

Feb 03, 2023

BUY
$3.27 - $5.5 $53,955 - $90,750
16,500 Added 0.87%
1,902,774 $6.28 Million
Q4 2021

Feb 07, 2022

BUY
$6.48 - $8.66 $3.44 Million - $4.59 Million
530,220 Added 39.1%
1,886,274 $12.2 Million
Q3 2021

Nov 05, 2021

BUY
$5.4 - $7.55 $7.32 Million - $10.2 Million
1,356,054 New
1,356,054 $9.4 Million

Others Institutions Holding INCR

About Intercure Ltd.


  • Ticker INCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,133,900
  • Market Cap $52.8M
  • Description
  • InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...
More about INCR
Track This Portfolio

Track Ibex Investors LLC Portfolio

Follow Ibex Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibex Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ibex Investors LLC with notifications on news.